Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells

被引：20
|
作者：
Lu, L. [1 ,2 ]
Saunders, V. A. [1 ]
Leclercq, T. M. [1 ,2 ]
Hughes, T. P. [1 ,2 ,3 ]
White, D. L. [1 ,2 ,4 ]
机构：
[1] South Australian Hlth & Med Res Inst SAHMRI, Canc Theme, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia
[3] SA Pathol, Dept Haematol, Adelaide, SA, Australia
[4] Univ Adelaide, Sch Med, Discipline Paediat, Adelaide, SA, Australia
来源：
LEUKEMIA | 2015年 / 29卷 / 08期
关键词：
IN-VITRO SENSITIVITY; IMATINIB MESYLATE; LEUKEMIA-CELLS; P-GLYCOPROTEIN; RESISTANCE; INHIBITOR; EFFLUX; ABL;
D O I：
10.1038/leu.2015.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1792 / 1794
页数：3
相关论文
共 50 条
  • [31] Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance
    Nimisha, Sundeep Singh
    Saluja, Sundeep Singh
    Sharma, Abhay Kumar
    Nekarakanti, Phani Kumar
    Apurva, Real Sumayya Abdul
    Kumar, Arun
    Sattar, Real Sumayya Abdul
    Anjum, Hasib
    Batra, Vineeta Vijay
    Husain, Syed Akhtar
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (10) : 2379 - 2394
  • [32] Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in mice
    Song, Yoo-Kyung
    Kim, Min-Ju
    Kim, Min-Soo
    Lee, Ji Hun
    Chung, Suk-Jae
    Song, Jin Sook
    Chae, Yoon-Jee
    Lee, Kyeong-Ryoon
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 173
  • [33] Effects of the ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of afatinib in healthy Chinese volunteers
    Tan, Yanan
    Cao, Kangna
    Ren, Guanghui
    Qin, Zhiying
    Zhao, Di
    Li, Ning
    Chen, Xijing
    Xia, Yufeng
    Lu, Yang
    XENOBIOTICA, 2020, 50 (02) : 237 - 243
  • [34] Aurones as Modulators of ABCG2 and ABCB1: Synthesis and Structure-Activity Relationships
    Sim, Hong May
    Loh, Ker Yun
    Yeo, Wee Kiang
    Lee, Chong Yew
    Go, Mei Lin
    CHEMMEDCHEM, 2011, 6 (04) : 713 - 724
  • [35] Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance
    Sundeep Singh Nimisha
    Abhay Kumar Saluja
    Phani Kumar Sharma
    Arun Nekarakanti
    Real Sumayya Abdul Apurva
    Hasib Kumar
    Vineeta Vijay Sattar
    Syed Akhtar Anjum
    Molecular and Cellular Biochemistry, 2023, 478 : 2379 - 2394
  • [36] Identification of putative steroid-binding sites in human ABCB1 and ABCG2
    Mares-Samano, Sergio
    Badhan, Raj
    Penny, Jeffrey
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (09) : 3601 - 3611
  • [37] ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
    El Biali, Myriam
    Karch, Rudolf
    Philippe, Cecile
    Haslacher, Helmuth
    Tournier, Nicolas
    Hacker, Marcus
    Zeitlinger, Markus
    Schmidl, Doreen
    Langer, Oliver
    Bauer, Martin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
    Yin, Wang
    Xiang, Dongxi
    Wang, Tao
    Zhang, Yumei
    Pham, Cuong, V
    Zhou, Shufeng
    Jiang, Guoqin
    Hou, Yingchun
    Zhu, Yimin
    Han, Yinglu
    Qiao, Liang
    Tran, Phuong H-L
    Duan, Wei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells
    Svirnovski, Arcadi I.
    Shman, Tatsiana V.
    Serhiyenka, Tatsiana F.
    Savitski, Valery P.
    Smolnikova, Victoria V.
    Fedasenka, Uladzimir U.
    HEMATOLOGY, 2009, 14 (04) : 204 - 212
  • [40] Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2
    Lin, Bing-Huan
    Li, Yen-Ching
    Murakami, Megumi
    Wu, Yu-Shan
    Huang, Yang-Hui
    Hung, Tai-Ho
    Ambudkar, Suresh. V.
    Wu, Chung-Pu
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
12345